Fluorogenic Trp(redBODIPY) cyclopeptide targeting keratin 1 for imaging of aggressive carcinomas

Keratin 1 (KRT1) is overexpressed in squamous carcinomas and associated with aggressive pathologies in breast cancer. Herein we report the design and preparation of the first Trp-based red fluorogenic amino acid, which is synthetically accessible in a few steps and displays excellent photophysical p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chemical science (Cambridge) Ročník 11; číslo 5; s. 1368 - 1374
Hlavní autoři: Subiros-Funosas, Ramon, Ho, Vivian Cheuk Lam, Barth, Nicole D, Mendive-Tapia, Lorena, Pappalardo, Morena, Barril, Xavier, Ma, Ruoyu, Zhang, Cheng-Bin, Qian, Bin-Zhi, Sintes, Miquel, Ghashghaei, Ouldouz, Lavilla, Rodolfo, Vendrell, Marc
Médium: Journal Article
Jazyk:angličtina
Vydáno: CAMBRIDGE Royal Soc Chemistry 2020
Royal Society of Chemistry
The Royal Society of Chemistry
Témata:
ISSN:2041-6520, 2041-6539
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Keratin 1 (KRT1) is overexpressed in squamous carcinomas and associated with aggressive pathologies in breast cancer. Herein we report the design and preparation of the first Trp-based red fluorogenic amino acid, which is synthetically accessible in a few steps and displays excellent photophysical properties, and its application in a minimally-disruptive labelling strategy to prepare a new fluorogenic cyclopeptide for imaging of KRT1+ cells in whole intact tumour tissues. Trp(redBODIPY) is the first red-emitting Trp-based amino acid for the preparation of fluorogenic peptides with retention of target binding affinity.
Bibliografie:Electronic supplementary information (ESI) available: Full synthetic procedures and chemical characterization, additional spectroscopic and biological data. See DOI
10.1039/c9sc05558d
Marie Curie Actions (MSCA)
European Research Council (ERC)
UKRI
researchfish
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2041-6520
2041-6539
DOI:10.1039/c9sc05558d